| scholarly article | Q13442814 |
| P50 | author | Emilie Javelle | Q90785789 |
| Fabrice Simon | Q90734945 | ||
| P2093 | author name string | Bernard-Alex Gaüzère | |
| Catherine Marimoutou | |||
| Anne Ribera | |||
| Isabelle Degasne | |||
| P2860 | cites work | Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity | Q95569720 |
| Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study | Q21195256 | ||
| Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study | Q21562246 | ||
| Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period | Q21562272 | ||
| Human muscle satellite cells as targets of Chikungunya virus infection | Q21562321 | ||
| Chikungunya virus infection | Q24497757 | ||
| Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness | Q27491022 | ||
| An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features | Q29620004 | ||
| Chikungunya in the Americas | Q30080031 | ||
| A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or compute | Q31120819 | ||
| Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies | Q33517926 | ||
| Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine | Q33700707 | ||
| Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. | Q33908108 | ||
| On chikungunya acute infection and chloroquine treatment | Q34012738 | ||
| The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy | Q34016674 | ||
| Ribavirin therapy for Chikungunya arthritis. | Q34019291 | ||
| MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. | Q34060999 | ||
| Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging | Q34099818 | ||
| Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 | ||
| Chikungunya infection in India: results of a prospective hospital based multi-centric study | Q34169886 | ||
| Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome | Q34200506 | ||
| Rheumatoid arthritic syndrome after chikungunya fever | Q34224013 | ||
| An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953 II. General description and epidemiology | Q34261544 | ||
| Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. | Q34269951 | ||
| Arthritogenic alphaviruses--an overview | Q34273343 | ||
| Chikungunya fever in travelers: clinical presentation and course | Q34580124 | ||
| American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. | Q34782898 | ||
| The invasive mosquito species Aedes albopictus: current knowledge and future perspectives | Q34896414 | ||
| Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. | Q35669675 | ||
| Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in sri lanka, in 2007: a longitudinal cohort study | Q35837865 | ||
| Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis | Q37331952 | ||
| Chikungunya-related arthritis: case report and review of the literature | Q38100901 | ||
| Chikungunya virus: an update on antiviral development and challenges | Q38107673 | ||
| Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis | Q38177507 | ||
| Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis | Q38225477 | ||
| Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations | Q38458316 | ||
| Chikungunya on Reunion Island. Experience, opinion, and proposals of general practitioners: poorly understood symptoms, lack of treatment protocol, exaggerated sequels, neglected players | Q38458335 | ||
| Corticosteroid therapy in an alphaviral arthritis | Q39286438 | ||
| Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe | Q40210825 | ||
| Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection | Q40218594 | ||
| Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus | Q40248768 | ||
| Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study | Q40305540 | ||
| Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study | Q40318152 | ||
| Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up. | Q40318663 | ||
| Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005-2006. | Q40364238 | ||
| A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years | Q40372969 | ||
| Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study | Q41918756 | ||
| Chikungunya disease and chloroquine treatment | Q41933000 | ||
| Chikungunya virus aches and pains: an emerging challenge | Q41940293 | ||
| Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection | Q42923192 | ||
| Chikungunya infection: a new trigger for psoriasis | Q43730713 | ||
| Chikungunya virus transmission found in the United States: US health authorities brace for wider spread | Q44145116 | ||
| A destructive arthropathy following Chikungunya virus arthritis--a possible association | Q44164039 | ||
| Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island | Q44849348 | ||
| Post-chikungunya chronic arthritis. | Q44849798 | ||
| Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island | Q44851009 | ||
| Chikungunya virus infection. A retrospective study of 107 cases | Q44851815 | ||
| Corticosteroids for the complications of Ross River virus infection. | Q45119148 | ||
| Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? | Q46229836 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chikungunya virus | Q15794049 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0003603 | |
| P577 | publication date | 2015-03-11 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. | |
| P478 | volume | 9 |
| Q40612454 | A Case of Chikungunya Virus Induced Arthralgia Responsive to Colchicine |
| Q40061039 | A Case of Initially Undiagnosed Chikungunya Arthritis Developing into Chronic Phase in a Nonendemic Area |
| Q28353979 | A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis |
| Q92298823 | A new multiplex RT-qPCR method for the simultaneous detection and discrimination of Zika and chikungunya viruses |
| Q47556754 | Amustaline (S-303) treatment inactivates high levels of Chikungunya virus in red-blood-cell components. |
| Q30240216 | Animal Models of Chikungunya Virus Infection and Disease. |
| Q64973940 | Arthritogenic Alphaviruses: A Worldwide Emerging Threat? |
| Q40046906 | Assessment of the Probability of Autochthonous Transmission of Chikungunya Virus in Canada under Recent and Projected Climate Change |
| Q28600065 | Blunting CHIKV infection by keeping T cells in check |
| Q38858594 | Brief Report: Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience |
| Q58727267 | Carpal tunnel syndrome observed after an arbovirus infection: A preliminary case series report |
| Q58575620 | Cellular and Molecular Immune Response to Chikungunya Virus Infection |
| Q27928037 | Chikungunya Virus Infection: An Update on Joint Manifestations and Management |
| Q41923135 | Chikungunya Virus-Associated Disease |
| Q38874607 | Chikungunya Virus: Current Perspectives on a Reemerging Virus. |
| Q90148719 | Chikungunya arthritis |
| Q44845048 | Chikungunya fever outbreak in Rio de Janeiro, Brazil: Ultrasonographic aspects of musculoskeletal complications. |
| Q26700081 | Chikungunya vaccines in development |
| Q47551657 | Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity |
| Q30235512 | Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies |
| Q36828876 | Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms? |
| Q40062417 | Clinical, Serological and Virological analysis of 572 chikungunya patients during the years 2010-2013 from India |
| Q39561285 | Congenital Chikungunya Virus Infection in Sincelejo, Colombia: A Case Series |
| Q58572770 | Contribution of the French army health service in support of expertise and research in infectiology in Africa |
| Q41919147 | Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study. |
| Q36290684 | Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus |
| Q38931911 | Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014. |
| Q38999094 | How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America? |
| Q39013750 | Immune-Mediated Protection and Pathogenesis of Chikungunya Virus |
| Q58801220 | Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses |
| Q57470981 | Infectious uveitis: an Asian perspective |
| Q47242810 | Lower temperatures reduce type I interferon activity and promote alphaviral arthritis |
| Q39128266 | Management of chikungunya arthritis |
| Q36260886 | Molecular Mimicry between Chikungunya Virus and Host Components: A Possible Mechanism for the Arthritic Manifestations |
| Q36018504 | Novel Lesions of Bones and Joints Associated with Chikungunya Virus Infection in Two Mouse Models of Disease: New Insights into Disease Pathogenesis |
| Q56448842 | Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study |
| Q24278918 | Ophthalmologic aspects of chikungunya infection |
| Q37722375 | Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016. |
| Q28804036 | Persistent RNA virus infections: do PAMPS drive chronic disease? |
| Q57905120 | Persistent Replication of a Chikungunya Virus Replicon in Human Cells Is Associated with Presence of Stable Cytoplasmic Granules Containing Nonstructural Protein 3 |
| Q40160164 | Persistent arthralgia and related risks factors in laboratory-confirmed cases of Chikungunya virus infection in Mexico |
| Q24288818 | Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia |
| Q59354319 | Prevalence and risk factors of post chikungunya rheumatic musculoskeletal disorders: a prospective follow-up study in French Guiana |
| Q38789052 | Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis |
| Q90262637 | Prevalence of chronic chikungunya and associated risks factors in the French West Indies (La Martinique): A prospective cohort study |
| Q55312161 | Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion island. |
| Q54253650 | Seroprevalence of Chikungunya Virus after Its Emergence in Brazil. |
| Q36809029 | That Which Bends Up: A Case Report and Literature Review of Chikungunya Virus. |
| Q64063959 | The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis |
| Q47114992 | The Identification of Risk Factors for Chronic Chikungunya Arthralgia in Grenada, West Indies: A Cross-Sectional Cohort Study |
| Q44843998 | Ultrasonography of Hands and Wrists in the Diagnosis of Complications of Chikungunya Fever. |
| Q98211921 | Update on the treatment of musculoskeletal manifestations in chikungunya fever: a guideline |
Search more.